Back
COVID-19 - Tocilizumab experience
Dr. Adri Kok | Clinical
Introduction to pathophysiology of COVID-19 pulmonary embolism and management, cytokine response, use of Tocilizumab and supportive care.
| Topic / Title of the Talk | COVID-19 - Tocilizumab experience |
| Field of Medicine | Critical Care |
| Length of the Talk | 13 Mins |
| CPD Accreditation No. | MDB015/MPDP/070/483 |
| Category of the Talk | Overview |
| CPD Type | Clinical |
| Languages (Translations) & Subtitles | Not Translated |
| Speaker | Dr. Adri Kok |
Talk Description
Introduction to pathophysiology of COVID-19 pulmonary embolism and management, cytokine response, use of Tocilizumab and supportive care. July 2020
Related Talkz
